Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective (Q37484011)

20 August 2017

1 reference

title

Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective (English)

1 reference

20 August 2017

0 references

0 references

Peter Findeisen

1

1 reference

20 August 2017

Michael Neumaier

series ordinal

2

1 reference

20 August 2017

publication date

1 January 2009

1 reference

Clinical Chemistry and Laboratory Medicine

20 August 2017

published in

1 reference

20 August 2017

volume

47

1 reference

20 August 2017

issue

6

1 reference

20 August 2017

page(s)

666-684

1 reference

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Achieving in-depth proteomics profiling by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Human Plasma PeptideAtlas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Mass spectrometry-based clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Alternative profiling platform based on MELDI and its applicability in clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Bioinformatics strategies for proteomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Urinary biomarker profiling in transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Protein profiling in urine for the diagnosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Serum biomarkers for detection of breast cancers: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

MALDI-TOF serum protein profiling for the detection of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

A Novel Approach Toward Development of a Rapid Blood Test for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomic profiling of urine for the detection of colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Identification of serum biomarkers for colon cancer by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Application of serum SELDI proteomic patterns in diagnosis of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Reduced transthyretin expression in sera of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Serum levels of variants of transthyretin down-regulation in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Study of distinct protein profiles for early diagnosis of NSCLC using LCM and SELDI-TOF-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Characterization of serum biomarkers for detection of early stage ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Glycomics analysis of serum: a potential new biomarker for ovarian cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

SELDI-TOF MS profiling of plasma proteins in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Diagnostic protein discovery using proteolytic peptide targeting and identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Possible detection of pancreatic cancer by plasma protein profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Diagnosis of pancreatic cancer using serum proteomic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Diagnostic potential of serum proteomic patterns in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Posttranslational modifications of transthyretin are serum markers in patients with mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Computational protein biomarker prediction: a case study for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Differential exoprotease activities confer tumor-specific serum peptidome patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Biomarker discovery in lung cancer--promises and challenges of clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Classification of cancer types by measuring variants of host response proteins using SELDI serum assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomics-driven cancer biomarker discovery: looking to the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteome analysis of bronchoalveolar lavage in lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Temperature range of thermodynamic stability for the native state of reversible two-state proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Two-dimensional electrophoresis of human urinary proteins following concentration by dye precipitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

A technical triade for proteomic identification and characterization of cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

MALDI imaging mass spectrometry: molecular snapshots of biochemical systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Tissue profiling by mass spectrometry: a review of methodology and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Mass spectrometry: uncovering the cancer proteome for diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Sample handling for mass spectrometric proteomic investigations of human sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Debate rages over proteomic patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Bias as a threat to the validity of cancer molecular-marker research

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Correcting common errors in identifying cancer-specific serum peptide signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

The minimum information about a proteomics experiment (MIAPE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Standards for systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Inflammatory protein profile during systemic high dose interleukin-2 administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Pathways connecting inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Strategies for plasma proteomic profiling of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Clinical proteomics: A need to define the field and to begin to set adequate standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Peptidomics for cancer diagnosis: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Extracellular proteases as targets for treatment of cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Local proteolytic activity in tumor cell invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteolysis in human breast and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

A streamlined platform for high-content functional proteomics of primary human specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Investigating diversity in human plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

LC-MS/MS quantification of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Application of bioaffinity mass spectrometry for analysis of ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Global and targeted quantitative proteomics for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomic analysis of human blood serum using peptide library beads

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Mapping of signaling pathways by functional interaction proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomic analysis of peripheral T lymphocytes, suitable circulating biosensors of strictly related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Cancer immunomics using autoantibody signatures for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomics, nanotechnology and molecular diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Sampling and analytical strategies for biomarker discovery using mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Proteomic Analysis of Peripheral Blood Mononuclear Cells: Selective Protein Processing Observed in Patients with Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Oncopeptidomics: A Useful Approach for Cancer Diagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Head-to-Head Comparison of Serum Fractionation Techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

Running before we can walk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.159

21 January 2018

Identifiers

DOI

10.1515/CCLM.2009.159

1 reference

20 August 2017

1 reference